Moxifloxacine Arrow (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacine Arrow, is a fluoroquinolone presented as an oral formulation for systemic use. It treats a range of bacterial infections, including pneumonia, sinusitis, bronchitis exacerbations, and skin‑structure infections, in adult patients when indicated.

GNH USA supplies Moxifloxacine Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacine Arrow is a fluoroquinolone antibacterial indicated for several bacterial infections. - Community‑acquired bacterial pneumonia: effective treatment of infection caused by susceptible organisms. - Acute bacterial sinusitis: resolves sinus inflammation due to susceptible pathogens. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves symptoms. - Skin and skin structure infections: eradicates susceptible skin‑associated bacteria and promotes healing.

Moxifloxacine Arrow may cause adverse reactions, which vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles tendon. - QT interval prolongation: cardiac rhythm disturbances that may cause palpitations. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Moxifloxacine Arrow, clinicians should consider several safety measures. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor cardiac status: watch for QT prolongation in patients with cardiac risk factors. - Avoid in known tendon disorders: increased risk of tendon rupture. - Use with caution in the elderly: higher incidence of adverse events. - Store at room temperature: keep in the original pack, protect from moisture.

Moxifloxacine Arrow can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Systemic corticosteroids: combined use raises tendon‑rupture risk. - Other QT‑prolonging drugs: may cause dangerous cardiac arrhythmias. - Antacids containing aluminum or magnesium: reduce moxifloxacin absorption.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Oral contraceptives: efficacy may be reduced, consider alternative contraception. - CYP450 inhibitors: can increase moxifloxacin plasma levels, necessitating dose review.